53.84USD-1.01%Mkt Cap: 13.48B $P/E: 17.10Today
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatme…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap13.48B $
Enterprise Value12.63B $
Revenue (TTM)2.44B $
Gross Profit2.24B $
Net Income (TTM)782.57M $
Revenue/Share9.333 USD
Last Price53.84 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30161Q1040
Valuation
P/E (Trailing)17.10
P/E (Forward)12.92
PEG2.56
EV/EBITDA12.38
EV/Revenue5.18
P/S5.46
P/B7.25
EPS (TTM)3.14
EPS (Forward)4.16
52W Range
33.7684% of range57.57
52W High57.57 USD
52W Low33.76 USD
Profitability
Gross Margin96.39%
Oper. Margin39.51%
EBITDA Margin41.89%
Profit Margin33.73%
ROE36.21%
ROA27.51%
Growth
Revenue Growth10.60%
Earnings Growth26.20%
Cash Flow & Leverage
Operating CF884.27M $
CapEx (TTM)39.93M $
FCF Margin30.37%
FCF Yield5.49%
Net Debt-673.46M $
Net Debt/EBITDA-0.66
Balance Sheet
Debt/Equity0.08
Current Ratio3.46
Quick Ratio3.24
Book Value/Sh7.408 USD
Cash/Share3.388 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)53.00 USD
Upside (mean)-1.6%
Target Range41.00 USD – 66.00 USD
$41.00-1.6% to mean$66.00
# Analysts17
Ownership
Shares Out.247.78M
Float214.12M
Insiders1.85%
Institutions107.19%
Short Interest
Short Ratio12.4d
Short % Float15.86%
Short % Out.11.60%
Shares Short28.75M
Short (prev mo.)28.54M
Technical
SMA 5054.21 (-0.7%)
SMA 20046.82 (+15.0%)
Beta0.42
S&P 52W Chg18.16%
Avg Vol (30d)2.44M
Avg Vol (10d)2.43M
Technical Indicators
RSI (14)52.5
MACD-0.6453
MACD Signal-0.4306
MACD Hist.-0.2147
BB Upper58.12 USD
BB Middle54.00 USD
BB Lower49.87 USD
BB Width15.28%
ATR (14)1.830 USD
Vol Ratio (20d)0.89x